Metformin is associated with a reduction in the number of COVID-19 cases

Published Date: 08 Mar 2023

The latest data on metformin in COVID show benefits in the disease.

Read Full News

Latest News

US Widens Lettuce-related Cyclosporiasis Probe to 20 States

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce ⁠from central Mexico after detecting cases in three additional...

US FDA Approves Updated COVID Vaccines for 2026-27 Season

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi ⁠and Pfizer-BioNTech's updated COVID vaccines, the companies said on Thursday, ⁠after an advisory...

HIV Resistance Assay Offers Quick, Low-Cost Results for RTs

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including dolutegravir, a first-line drug with growing resistance.

Congo Starts Ebola Vaccinations for Health Workers

Democratic Republic of Congo on Thursday began vaccinating frontline health workers with a vaccine ⁠approved for a different Ebola species, as authorities seek to contain...

Dolutegravir ART Receives FDA Approval for Newborns With HIV

As the first second-generation INSTI approved for newborns with HIV, this approval allows for a simpler, more robust antiretroviral therapy regimen than existing standard of care.

Groups Work to Save Lives as Ebola Spreads in Central Africa

Even though the virus has faded from US headlines, key organizations are still at work providing medical care and training to counter the spread of the disease.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce ⁠from central Mexico after detecting cases in three additional...

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi ⁠and Pfizer-BioNTech's updated COVID vaccines, the companies said on Thursday, ⁠after an advisory...

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including dolutegravir, a first-line drug with growing resistance.

Democratic Republic of Congo on Thursday began vaccinating frontline health workers with a vaccine ⁠approved for a different Ebola species, as authorities seek to contain...

As the first second-generation INSTI approved for newborns with HIV, this approval allows for a simpler, more robust antiretroviral therapy regimen than existing standard of care.

Even though the virus has faded from US headlines, key organizations are still at work providing medical care and training to counter the spread of the disease.

News All Time

Dengue Cases Surge in Malaysia's Klang Valley, Says Health Ministry

Dengue fever cases have surged in the Malaysian capital Kuala Lumpur and the surrounding Klang Valley area, the ⁠country's health ministry said on Friday, warning of a high...

Michigan Reports About 3% Weekly Rise in Cyclosporiasis Cases as Outbreak Begins to Slow

Michigan's health department on Thursday reported 14,277 cases linked to a cyclosporiasis outbreak, up 368 or about 3% from a week earlier, with the slower ⁠pace of increase...

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine for Ebola, the World Health ⁠Organization said on Thursday, as the country...

Lenacapavir PrEP: No New HIV infections & High Satisfaction

Participants in the PURPOSE 1 trial particularly appreciated the convenience of not needing a daily pill and the confidence of feeling protected from HIV long-term.

Ebola Cases in Congo Exceed 5,000, Government Data Shows

The number of confirmed Ebola cases in the Democratic Republic ⁠of Congo now exceeds 5,000, government data showed late on Tuesday, as ⁠health officials warn that response...

Kids With Complex Conditions Face Higher Antibiotic Exposure

Children with complex chronic conditions have a higher likelihood of receiving antibiotic prescriptions than their healthy peers.

Doravirine Add-On Boosts Virologic Control in HIV Infection

Adding doravirine to an existing antiretroviral regimen helps people living with HIV regain virologic control, especially when background drugs remain active.

WHO Says Congo Ebola Outbreak Can Still Be Brought Under Control Within Three Months

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

Do TZP-Resistant Bloodstream Infections Raise Death Risk?

Piperacillin-tazobactam resistance does not increase mortality risk in patients with bloodstream infections after accounting for baseline risk factors, a recent study shows.

Data Trends: Pneumococcal Disease Prevention

Pneumococcal disease prevention is evolving fast with updated vaccine recommendations for adults 50+ and exciting next-generation vaccines on the horizon.

Ebola Outbreak in Democratic Republic Of Congo Becomes Deadliest in Country's History

The Ebola outbreak in Democratic Republic of Congo has killed 2,325 people, government data showed on Sunday, surpassing the toll from the 2018-2020 outbreak to become the...

Netherlands Reports First West Nile Virus Infection in 6 Years

A West Nile virus infection has ⁠been detected in the Netherlands for the first ⁠time since 2020, Dutch public health institution ⁠RIVM said on ‌Monday.

Doxycycline Cuts Recurrent Rectal Chlamydia Risk

A shift in prescribing practices at a Seattle sexual health clinic corresponded with a notable decline in recurrent rectal chlamydia cases among men who have sex with men.

Zoetis Gets US FDA Emergency Use Nod for Treatment for Screwworm in Dogs

The U.S. Food and Drug Administration on Thursday issued an emergency use authorization for Zoetis' ⁠flea and tick drug to treat New World screwworm (NWS) infestations in...

Changes to NVAC Trigger Concerns

The HHS is seeking new members who can discuss immunization alternatives like ‘healthy lifestyle’ strategies and dietary supplements.

Congo Says Ebola Outbreak Spreads to Northeastern Bas-Uele Province

The Ebola outbreak in Democratic Republic of ⁠Congo has spread to a sixth province, Bas-Uele, located in ⁠the northeast of the country, the communications ministry ⁠said on...

Recommended News For You

Mindfulness-based interventions are advised by cancer organizations to treat patients' anxiety and depression.

The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

CAR-T cell therapy for cancer causes 'brain fog,' study shows

Recommended Articles For You

Obesity is a major risk factor for cancer 

Lymphomatoid Papulosis: What You Need to Know 

Immune Landscape Evolution in the Tumor Stromal Ecosystem 

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

2.

Brain cancer: a Q&A session.

3.

Women are more susceptible to the stress caused by inflation.

4.

Use of social media during pregnancy may increase depression.

5.

A new theranostic drug targets different cancer types.

1.

Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy

2.

How HLH is Revolutionizing Healthcare

3.

Unraveling the Mysteries of Burkitt Lymphoma: A New Hope for Treatment

4.

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management

5.

Rehabilitation Through Prehabilitation Before Complex Cancer Surgery

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

3.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

5.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot